North America Label Free Detection Market
The growth of the market is attributed to the rapid proliferation of the pharmaceuticals and biotechnology industries, increasing adoption of innovative approaches in drug discovery, and rising government initiatives and funding for R&D. However, the lack of skilled professionals restricts the market growth.
Label free technologies are relatively new in the well-established high-throughput screening (HTS) field. The technologies probe biomolecular interactions without getting affected by spatial interference, or auto-fluorescence or quenching repercussions of labels. On average, a new drug takes at least a decade to complete the journey from initial discovery to commercial launch. According to the Pharmaceutical Research and Manufacturers of America (PhRMA), the average cost of research & development for every successful drug is ~ US$ 2.6 billion. With the rising costs of drug development to treat increasingly complex diseases, improving productivity in early drug discovery processes has been challenging.
Initially, low throughput was a significant challenge associated with label free technologies. However, the introduction of surface plasmon resonance-based (SPR-based) label free systems with higher throughput has increased the overall operational efficiency of these systems while providing valuable data to make informed decisions.
• The latest innovation in differential scanning calorimetry (DSC) by Spectris is designed specifically for regulated environments, and the innovative technique delivers essential data to guide biopharmaceutical development. In 2017, Spectris introduced the MicroCal PEAQ-DSC microcalorimeter, which offers 24-hour operations, streamlined workflows, and automated data analysis to produce results in hours, driving productivity and efficiency gains in research and production.
• In 2018, Danaher introduced Biacore 8K+, an eight-needle, high-sensitivity SPR system. The system automates over 4,500 experiments focused on binding between drug candidates and specific disease targets. It can be connected with the Biacore Insight Evaluation Software to translate high-quality data into actionable insights.
• In 2019, Agilent Technologies introduced a unique multimode real-time cell analyzer (RTCA), which blends the best of noninvasive biosensor measurements with live-cell imaging. These advancements provide label-free, real-time biosensor measurements and kinetic imaging of the same live cell populations, independently or simultaneously. This revolutionizes cell analysis in life science research.
• In 2020, Nicoya launched Alto, a fully automated, high-throughput benchtop SPR system. It uses digital microfluidics (DMF) that replaces physical pumps, valves, or tubes with low-cost disposable cartridges. This lowers the time and cost of drug discovery, enabling scientists to understand better and fasten the process of obtaining the cure for human diseases.
Therefore, due to technological advancements, pharmaceutical and biopharmaceutical companies and academic research institutes adopt label-free technologies for biomolecular analysis during drug discovery, which fuels the growth of the label-free detection market.
The North America label free detection market based on the product is segmented into instruments and consumables. Based on technology, the North America label free detection market is segmented into surface plasmon resonance, bio-layer interferometry, isothermal titration calorimetry, differential scanning calorimetry, and other LFD technologies. The North America label free detection market, based on application is segmented into binding kinetics, binding thermodynamics, endogenous receptor detection, hit confirmation, lead generation, and other applications. The North America label free detection market, based on end user is segmented into pharmaceutical and biotechnology companies, academic and research institutes, contract research organizations and other end users. Geographically, the North America label free detection market can be divided into US, Canada, and Mexico.
General Electric, Perkin Elmer, Inc., AMETEK Inc., F. HOFFMANN-LA ROCHE LTD., Spectris, METTLER TOLEDO, Agilent Technologies, Inc., Waters Corporation, Sartorius AG and Corning Incorporated are among the leading companies operating in the North America label free detection market.
Strategic insights for the North America Label Free Detection provides data-driven analysis of the industry landscape, including current trends, key players, and regional nuances. These insights offer actionable recommendations, enabling readers to differentiate themselves from competitors by identifying untapped segments or developing unique value propositions. Leveraging data analytics, these insights help industry players anticipate the market shifts, whether investors, manufacturers, or other stakeholders. A future-oriented perspective is essential, helping stakeholders anticipate market shifts and position themselves for long-term success in this dynamic region. Ultimately, effective strategic insights empower readers to make informed decisions that drive profitability and achieve their business objectives within the market.
| Report Attribute | Details |
|---|---|
| Market size in 2021 | US$ 171.84 Million |
| Market Size by 2028 | US$ 306.08 Million |
| Global CAGR (2021 - 2028) | 8.6% |
| Historical Data | 2019-2020 |
| Forecast period | 2022-2028 |
| Segments Covered |
By Product
|
| Regions and Countries Covered | North America
|
| Market leaders and key company profiles |
The geographic scope of the North America Label Free Detection refers to the specific areas in which a business operates and competes. Understanding local distinctions, such as diverse consumer preferences (e.g., demand for specific plug types or battery backup durations), varying economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved areas or adapting their offerings to meet local demands. A clear market focus allows for more effective resource allocation, targeted marketing campaigns, and better positioning against local competitors, ultimately driving growth in those targeted areas.
The North America Label Free Detection Market is valued at US$ 171.84 Million in 2021, it is projected to reach US$ 306.08 Million by 2028.
As per our report North America Label Free Detection Market, the market size is valued at US$ 171.84 Million in 2021, projecting it to reach US$ 306.08 Million by 2028. This translates to a CAGR of approximately 8.6% during the forecast period.
The North America Label Free Detection Market report typically cover these key segments-
The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the North America Label Free Detection Market report:
The North America Label Free Detection Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:
The North America Label Free Detection Market report is valuable for diverse stakeholders, including:
Essentially, anyone involved in or considering involvement in the North America Label Free Detection Market value chain can benefit from the information contained in a comprehensive market report.
Office No. 1011, First floor, Farena Corporate Park, Magarpatta-Mundhwa road, Pune - 411028, Maharashtra, India
US:+16467917070
sales@businessmarketinsights.com
Get Free Sample For North America Label Free Detection Market
